Diabetes Conferences | Diabetes Meetings | Diabetes Events | Europe | USA | Asia Pacific| 2016| Conference Series LLC LTD

Theme: New Therapeutic Mechanisms of Diabetes

Euro Diabetes 2016

Euro Diabetes 2016

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Track 1: Complications associated with Diabetes

The term diabetes mellitus describes several diseases of abnormal carbohydrate metabolism that are characterized by hyperglycaemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of peripheral resistance to the action of insulin. They are derived after doing many clinical trials on animal models. Every few years, the diabetes community revaluates the current recommendations for the classification, diagnosis, and screening of diabetes, reflecting new information from research and clinical practice which in turns help in understanding current prevention and treatment options and cost effectiveness in treatment and prevention of Diabetes. People with type1 and type2 diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the Macro vascular and micro vascular complications. In addition, people with diabetes also have a higher risk of developing infections. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation. Maintaining blood glucose levels, blood pressure, and cholesterol at or close to normal can help delay or prevent diabetes complications. Hypoglycaemia and Hyperglycaemia are the other two factors are the two major complications of diabetes where hyperglycaemia is an acute complication sharing many symptoms and hypoglycaemia is an acute complication of several diabetes treatments. Glycosylated haemoglobin is a form of haemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.

Related Conferences of Complications associated with Diabetes

Diabetes Conferences Europe September 15-17, 2016, Germany; 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, UAE; International Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA; 11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia; 9thGlobal Diabetologists Annual Meeting and Medicare Expo, June 06-08, 2016, USA; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan;Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 2: Genetics of Diabetes

Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes (e.g., maturity-onset diabetes of the young), the majority of genetic risk of diabetes (for type 1 and type 2) remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies. Diabetic amyotrophic is a disabling illness that is distinct from other forms of diabetic neuropathy.

Related Conferences of Genetics of Diabetes

Track 3: Endocrinology: Disorders and Treatment

Endocrinology is the study of hormones and the treatment of hormone based diseases. The endocrine glands produce chemicals called hormones. These hormones are released into the blood stream and exert their action by stimulating other organs in the body. However, Clinical trials on endocrinology look at new ways to prevent, detect, or treat disease. The major endocrine glands are the thyroid, pancreas, parathyroid, adrenal, gonad and pituitary. The hormones from these glands regulate growth, metabolism, blood pressure, reproduction as well as many other necessary functions. Early Diagnosis and Treatment of Endocrine Disorders, written by a distinguished panel of clinical experts and research scientists, focuses on the early signs and symptoms of common endocrine diseases, surveys the clinical testing needed for a diagnosis, and concisely presents the best current recommendations for therapy. Paediatric endocrinology is a medical subspecialty that studies and treats conditions affecting physical growth and sexual development in children, as well as diabetes and other disorders of the endocrine (hormone) glands.

Related Conferences of Endocrinology: Disorders and Treatment

Track 4: Advanced Technologies for the Treatment of Diabetes

The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace (e.g. insulin pumps, rapid HbA1c monitoring, etc come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed (e.g. the Glucowatch), regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.

Related Conferences of Advanced Technologies for the Treatment of Diabetes

Track 5: Diabetes Management

The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment. Healthy eating is a cornerstone of healthy living — with or without diabetes. But if you have diabetes, you need to know Impact of Food and Nutrition, impact of physical activity and yoga therapy in Diabetes Management. Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. Standards of medical care in Diabetes increased when compared to previous year.

Related Conferences of Diabetes Management

Track 6: Emerging Focus in Diabetes Research

Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned. Diabesity can be defined as a metabolic dysfunction that ranges from mild blood sugar imbalance to full-fledged type 2 diabetes. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal.

Related Conferences of Emerging Focus in Diabetes Research

Track 7: Transplantation of Diabetes

Getting a new heart, liver, kidney, lung, or other organ can save your life. Sometimes, it can also lead to type 2 diabetes. Many people can stop taking steroids after 6 months or so. This may solve the problem. If scientists can develop safe immunosuppressant’s that always work, then many people with type 1 diabetes may choose to have pancreas transplants. Until then, many doctors think islet transplants are a better option even after performing clinical trials on islet transplants. Islets are clusters of cells in the pancreas that make insulin. In people with type 1 diabetes, islet cells are destroyed. Only 1-2% of the pancreas is made up of islet cells. In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin. A transplant of the pancreas is usually reserved for those with serious complications. Pancreas transplants are most often done when a patient also receives a new kidney. The pancreas transplant adds little further risk in this situation and offers big benefits. However, transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks. Xenotransplantation for the treatment of type 1 diabetes is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. Bolus insulin needs to act quickly and so short acting insulin or rapid acting insulin will be used where as Conventional insulin therapy is a therapeutic regimen for treatment of diabetes mellitus which contrasts with the newer intensive insulin therapy.

Related Conferences of Transplantation of Diabetes

Track 8: Diabetes Research in Clinical Practice

Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management control have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction.

Related Conferences of Diabetes Research in Clinical Practice

Track 9: Computational Biology of Diabetes

Computational meta-analysis can link environmental chemicals to genes and proteins involved in human diseases, thereby elucidating possible aetiologies. The recent rapid development of a variety of analytical platforms based on mass spectrometry and nuclear magnetic resonance have enabled identification of complex metabolic Syndrome phenotypes. Continued development of bioinformatics and analytical strategies has facilitated the discovery of causal links in understanding the pathophysiology of diabetes and its complications.

Related Conferences of Computational Biology of Diabetes

Diabetes Conferences Europe September 15-17, 2016, Germany; 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, UAE; International Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA; 11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia; 9thGlobal Diabetologists Annual Meeting and Medicare Expo, June 06-08, 2016, USA; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 10: Risk Factors and Related Diseases of Diabetes

Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.

Related Conferences of Risk Factors and Related Diseases of Diabetes

Accreditation Statement

Designation Statement

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications acute complications include diabetic ketoacidosis and nonketotic hyperosmolar coma. Serious long-term complications include cardiovascular disease, stroke, chronic kidney failure, foot ulcers, and damage to the eyes.

It takes us immense pleasure to announce the next conference that is 12^th European Diabetes Congress which is going to be held from September 15-17 at Berlin, Germany.

OMICS International invites Diabetes expertise, researchers, professors, scientific communities, therapists, counsellors, delegates, students, business professionals and executives to attend 12^th European Diabetes Congress which is going to be held on September 15-17, 2016 at Berlin, Germany. OMICS International Organizes organizes 1000+ Global events inclusive of 300+ Conferences every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

For more conferences, please visit Conference Series

Prevalence of diabetes is increasing among all ages in Europe, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. There are about 60 million people with diabetes in the European Region, or about 10.3% of men and 9.6% of women aged 25 years and over.

Worldwide, high blood glucose kills about 3.4 million people annually. Almost 80% of these deaths occur in low- and middle-income countries, and almost half are people aged less than 70 years. WHO projects diabetes deaths will double between 2005 and 2030.

Why to attend???

Medical doctors, patients and health care providers consider the prevention of Diabetes as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey. Realizing this imperative, OMICS Group is set to organize International Conference on Diabetes for the upcoming year with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered.

Target Audience:

Diabetes students, Scientists
Diabetes Researchers
Diabetes Faculty
Medical Colleges
Diabetes Associations and Societies
Business Entrepreneurs
Training Institutes
Manufacturing Medical Devices Companies

Diabetes mellitus, commonly referred to as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications include diabetic ketoacidosis and non ketotic hyperosmolar coma. Serious long-term complications include cardiovascular disease, stroke, chronic kidney failure, foot ulcers, and damage to the eyes. Diabetes is a way to carefully test a new drug or device in patients before it is approved by the FDA to be used in the general public.

Diabetes Clinical trials are an important step in our being able to have new treatments for diabetes and other conditions. Clinical trials offer the opportunity to play an active role in their own health care and to access potential new treatments before they are widely available.

Young Researcher Sessions are organized at the Euro Diabetes Conference to provide a unique platform for young researcher/investigators for presenting latest research projects with an in-depth analysis. The use of “diabetes guidelines” or “diabetes algorithm” as search terms will yield greater than 8,900 and 3,100 citations, respectively. European Diabetes Guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical medical decision- making. In 1999, the European Association for the Study of Diabetes (EASD) increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD). The Foundation is closely related to the EASD; it is governed exclusively by the Executive Committee of the EASD, which itself is under the close supervision of the EASD Council and the General Assembly of the EASD. On the other hand Endocrinology which is closely related to diabetes is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. The European congress of Endocrinology is an organization established to promote endocrinology in Europe. European Diabetes which is a large International Exhibition carries the main agenda of joining the people and experts related to diabetes from different countries. Prevalence of Diabetes is increasing among all ages in Europe, mostly due to increase in over weight and obesity, unhealthy diet and physical inactivity. There are about 60 Million people with diabetes in the European region, or about 10.3% of men and 9.6% of women aged 25 years and over. European diabetes 2016 aims in updating the recent and most advanced research developments that has taken place in the field of Diabetes. A wide number of diabetes congresses are conducted all over the world to create awareness among the people about the new inventions, discoveries and techniques to overcome the diabetes. This Euro Diabetes Association gives a strong commitment to advance the overall quality of our research activities in the field of diabetes and achieve even greater penetration in the diagnostics and management of patients with suspected or proven disease. European Diabetes Conference attendees leave the meeting feeling inspired and exhilarated to continue and improve our own clinical and research practice, with improved knowledge on most innovative technology and original advances in diabetes therapy and management. European Diabetes conference helps all young students and student communities to meet diabetes experts around the world. Diabetes Association plays a vital role in improving and updating the knowledge on diabetes recent research and advancements. This World Diabetes Conference helps in improving the quality of Diabetes research all over the world with a focused aim of bringing together the dialectologist from different countries. Many other associations such as Juvenile Diabetes Association, IDF world diabetes congress are putting their greatest effort to reduce the rate of diabetic patients all over the world. All over the world, World Diabetes Association are playing a very important role in advancing the research and improving the quality of research.

Scope and Importance of Diabetes

Diabetes is globally familiar as one of the foremost causes of death and incapacity in the United States. In 2000, it was the sixth chief cause of death. About 65% of deaths within people living with diabetes are attributed to stroke and heart disease. Diabetes is related with long-term complications that affect almost each and every part of the body. Unrestricted diabetes can confuse pregnancy, and birth flaws are more common in babies born to women with diabetes. The task of the International Diabetes Federation is to encourage diabetes care, prevention and a cure worldwide. Clinical trials are an vital step in our being able to have new treatments for diabetes and other conditions.

Why Berlin (Germany)?

"Alone in Germany around eight million people are affected by diabetes mellitus, and according to current estimates, just as many have undiagnosed diabetes or have a high diabetes risk", State Secretary Braun said in his speech in Berlin. Germany is roughly the size of Texas or Italy, but it actually ranks first with all things diabetes. 7.5 million Diagnosed cases make it top of the list in Europe.

Societies associated with diabetes research

To inspire, educate, apprise and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the world to professionally avoid and combat the lethal disease

Major diabetes association in Germany:

· Diabetes- Clinic

· Diabetes- Academy

· FIDAM GmbH

· InsulinJA

Major diabetes association in Europe:

· European association for the study of diabetes

· European diabetes foundation

· Diabetes Association Switzerland

· Spanish Diabetes Society (Spain)

· Swedish Diabetes Association

Major diabetes association in USA:

· American Diabetes Association

· American Association of Clinical Endocrinologists

· Centre for Disease Control: Division of Diabetes Translation

· Diabetes Advocacy Alliance

· Diabetes Hands Foundation

· Juvenile Diabetes Foundation International

· National Kidney Foundation

· National Institute of Diabetes and Digestive and Kidney Diseases

Major Diabetes Associations around the Globe:

· Diabetes Indian Association

· Canadian Diabetes Association

· International Diabetes Federation

· Diabetes Australia

· Austrian Diabetes Association.

· Diabetes South Africa

· Asia diabetes foundation

· Asian association for the study of diabetes

· Korean Diabetes Association

Market research on diabetes

Diabetes industry guides to the 11 largest pharmaceutical and diagnostic companies producing diabetes related products or those involved with diabetes research. Diabetes is a major problem in the UK, and as such a large healthcare and treatment industry has built up around it.Diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market.

Global prevalence of diabetes

One in 10 people globally will have diabetes by 2035, according to a concerning new report.To highlight World Diabetes Day which takes place each year on Nov. 14, the International Diabetes Federation (IDF) released its sixth edition of the Diabetes Atlas. The report estimates how many adults between the ages of 20 to 79 will be affected by the disease in the future. By the end of this year, the IDF estimates that 382 million people will have diabetes around the world. By 2035, that number will skyrocket to 592 million. For comparison, about 285 million people had the disease just four years ago. Eighty percent of people with the disease live in low- and middle-income countries, and most of them are between 40 and 59 years old. The organization also said that one person dies from diabetes every six seconds, or about 5.1 million deaths annually.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 15-17, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

"I must tell you that everything was very well organized I enjoyed the meeting very much. Thus, thank you very much for your attentions."
Emilio Herrera
Spain

"I enjoyed the conference, it was a wonderful experience, in all professional aspects. I became aware of new findings and trends in my research area, discussed them with the finest scientists all over the world, everything in a gorgeous place with superb facilities. It was indeed a remarkable experience."
Massimo Collino
Italy

"Thank you very much.I really enjoyed Euro Diabetes in Valencia.Hope to go in Germany as well."
Jazlina
Malaysia

"The conference was well-organized with a great benefit."
Saleem Bhanihani

"It was a great opportunity for me to meet international experts in the field of diabetes"
Akbar Shafiee

"It was a great experience for me to participate in the 8th Euro diabetes Expo in Valencia, spain. Share with other researchers of diferent countries was enriching from many points of view. I would like to have another opportunity to be again and learn from other experiences in the different research fields"
Lourdes Cristina
Mexico

12^th European Diabetes Congress September 15-17, 2016 Berlin, Germany

Recommended Global Diabetes & Endocrinology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links